115 related articles for article (PubMed ID: 11496990)
1. HPIC-UV-ICP-SFMS study of the interaction of cisplatin with guanosine monophosphate.
Hann S; Zenker A; Galanski MS; Bereuter TL; Stingeder G; Keppler BK
Fresenius J Anal Chem; 2001 Jul; 370(5):581-6. PubMed ID: 11496990
[TBL] [Abstract][Full Text] [Related]
2. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry.
Küng A; Strickmann DB; Galanski MS; Keppler BK
J Inorg Biochem; 2001 Oct; 86(4):691-8. PubMed ID: 11583787
[TBL] [Abstract][Full Text] [Related]
4. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
Yamada K; Kato N; Takagi A; Koi M; Hemmi H
Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
[TBL] [Abstract][Full Text] [Related]
5. Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin.
Timerbaev AR; Aleksenko SS; Polec-Pawlak K; Ruzik R; Semenova O; Hartinger CG; Oszwaldowski S; Galanski M; Jarosz M; Keppler BK
Electrophoresis; 2004 Jul; 25(13):1988-1995. PubMed ID: 15237398
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent interactions of platinum(II) complexes with 5'-GMP under simulated physiological conditions studies by capillary electrophoresis.
Zenker A; Galanski M; Bereuter TL; Keppler BK; Lindner W
J Biol Inorg Chem; 2000 Aug; 5(4):498-504. PubMed ID: 10968621
[TBL] [Abstract][Full Text] [Related]
7. Conformer distribution in (cis-1,4-DACH)bis(guanosine-5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin.
Ranaldo R; Margiotta N; Intini FP; Pacifico C; Natile G
Inorg Chem; 2008 Apr; 47(7):2820-30. PubMed ID: 18284193
[TBL] [Abstract][Full Text] [Related]
8. The influence of methionine-containing peptides on the reaction of carboplatin with 5'-guanosine monophosphate: a comparison with cisplatin.
Kleine M; Wolters D; Sheldrick WS
J Inorg Biochem; 2003 Dec; 97(4):354-63. PubMed ID: 14568240
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin--DNA cross-link models with an unusual type of chirality-neutral chelate amine carrier ligand, N,N dimethylpiperazine (Me2ppz): Me2ppzPt(guanosine monophosphate)2 adducts that exhibit novel properties.
Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
Inorg Chem; 2000 Feb; 39(4):836-42. PubMed ID: 11272585
[TBL] [Abstract][Full Text] [Related]
10. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
Bierbach U; Sabat M; Farrell N
Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
[TBL] [Abstract][Full Text] [Related]
11. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of binding properties of 5'-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis.
Zenker A; Galanski M; Bereuter TL; Keppler BK; Lindner W
J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(1):211-9. PubMed ID: 10997716
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of and platinum(II) migration in the reactions of tetrazolato-bridged dinuclear platinum(II) complexes with nucleotides.
Uemura M; Komeda S
J Inorg Biochem; 2017 Dec; 177():359-367. PubMed ID: 28893417
[TBL] [Abstract][Full Text] [Related]
14. Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles.
Peleg-Shulman T; Najajreh Y; Gibson D
J Inorg Biochem; 2002 Jul; 91(1):306-11. PubMed ID: 12121789
[TBL] [Abstract][Full Text] [Related]
15. In vivo detection of DNA adducts induced by cisplatin using capillary HPLC-ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster.
García Sar D; Montes-Bayón M; Aguado Ortiz L; Blanco-González E; Sierra LM; Sanz-Medel A
Anal Bioanal Chem; 2008 Jan; 390(1):37-44. PubMed ID: 17932658
[TBL] [Abstract][Full Text] [Related]
16. Effect of geometric isomerism in dinuclear platinum antitumour complexes on the rate of formation and structure of intrastrand adducts with oligonucleotides.
Mellish KJ; Qu Y; Scarsdale N; Farrell N
Nucleic Acids Res; 1997 Mar; 25(6):1265-71. PubMed ID: 9092638
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs.
Corte-Rodríguez M; Espina M; Sierra LM; Blanco E; Ames T; Montes-Bayón M; Sanz-Medel A
Biochem Pharmacol; 2015 Nov; 98(1):69-77. PubMed ID: 26352094
[TBL] [Abstract][Full Text] [Related]
18. Optimized sample preparation strategy for the analysis of low molecular mass adducts of a fluorescent cisplatin analogue in cancer cell lines by CE-dual-LIF.
Zabel R; Kullmann M; Kalayda GV; Jaehde U; Weber G
Electrophoresis; 2015 Feb; 36(4):509-17. PubMed ID: 25483804
[TBL] [Abstract][Full Text] [Related]
19. Reaction monitoring of platinum(II) complex--5'-guanosine monophosphate adduct formation by ion exchange liquid chromatography/electrospray ionization mass spectrometry.
Zöllner P; Zenker A; Galanski M; Keppler BK; Lindner W
J Mass Spectrom; 2001 Jul; 36(7):742-53. PubMed ID: 11473397
[TBL] [Abstract][Full Text] [Related]
20. Binding of the anticancer drug cis-dichlorodiammineplatinum to 3'(2')-guanosine monophosphate and nucleic acids.
Theophanides T; Ganguli PK; Bertrand MJ
Anticancer Res; 1981; 1(6):383-8. PubMed ID: 6284018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
